242 related articles for article (PubMed ID: 14624137)
1. Statin therapy and angiogenesis.
Skaletz-Rorowski A; Walsh K
Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
[TBL] [Abstract][Full Text] [Related]
2. The pro- and antiangiogenic effects of statins.
Skaletz-Rorowski A; Kureishi Y; Shiojima I; Walsh K
Semin Vasc Med; 2004 Nov; 4(4):395-400. PubMed ID: 15861320
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
4. Statins, nitric oxide and neovascularization.
Ma FX; Han ZC
Cardiovasc Drug Rev; 2005; 23(4):281-92. PubMed ID: 16614729
[TBL] [Abstract][Full Text] [Related]
5. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Kureishi Y; Luo Z; Shiojima I; Bialik A; Fulton D; Lefer DJ; Sessa WC; Walsh K
Nat Med; 2000 Sep; 6(9):1004-10. PubMed ID: 10973320
[TBL] [Abstract][Full Text] [Related]
6. Role of Akt signaling in vascular homeostasis and angiogenesis.
Shiojima I; Walsh K
Circ Res; 2002 Jun; 90(12):1243-50. PubMed ID: 12089061
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells.
Skaletz-Rorowski A; Lutchman M; Kureishi Y; Lefer DJ; Faust JR; Walsh K
Cardiovasc Res; 2003 Jan; 57(1):253-64. PubMed ID: 12504836
[TBL] [Abstract][Full Text] [Related]
9. Double-edged role of statins in angiogenesis signaling.
Urbich C; Dernbach E; Zeiher AM; Dimmeler S
Circ Res; 2002 Apr; 90(6):737-44. PubMed ID: 11934843
[TBL] [Abstract][Full Text] [Related]
10. [Participation of the phosphatidylinositol-3-kinase/Akt/endothelial-nitric-oxide synthase signaling in the processes of angiogenesis and vascular remodeling].
Morales M
Nefrologia; 2002; 22 Suppl 5():13-6. PubMed ID: 12107910
[No Abstract] [Full Text] [Related]
11. HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium.
Chen JX; Lawrence ML; Cunningham G; Christman BW; Meyrick B
J Appl Physiol (1985); 2004 Feb; 96(2):612-20. PubMed ID: 14555685
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
13. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
14. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells.
Wang J; Tokoro T; Matsui K; Higa S; Kitajima I
Life Sci; 2005 Mar; 76(19):2257-68. PubMed ID: 15733940
[TBL] [Abstract][Full Text] [Related]
15. Statins have biphasic effects on angiogenesis.
Weis M; Heeschen C; Glassford AJ; Cooke JP
Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
[TBL] [Abstract][Full Text] [Related]
16. Emerging mechanisms for secondary cardioprotective effects of statins.
Miller SJ
Cardiovasc Res; 2001 Oct; 52(1):5-7. PubMed ID: 11557228
[No Abstract] [Full Text] [Related]
17. The effects of statins on endothelium, inflammation and cardioprotection.
Elrod JW; Lefer DJ
Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
Dimmeler S; Aicher A; Vasa M; Mildner-Rihm C; Adler K; Tiemann M; Rütten H; Fichtlscherer S; Martin H; Zeiher AM
J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
[TBL] [Abstract][Full Text] [Related]
19. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells.
Walter DH; Zeiher AM; Dimmeler S
Coron Artery Dis; 2004 Aug; 15(5):235-42. PubMed ID: 15238818
[TBL] [Abstract][Full Text] [Related]
20. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway.
Chavakis E; Dernbach E; Hermann C; Mondorf UF; Zeiher AM; Dimmeler S
Circulation; 2001 Apr; 103(16):2102-7. PubMed ID: 11319202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
